CB
C Frank Bennett
EVP, Chief Scientific Officer

C Frank Bennett insider trades: Ionis Pharmaceuticals (IONS) stock sales

EVP, Chief Scientific Officer, Ionis Pharmaceuticals Last trade Jul 7, 2026 130 Form 4 filings
$16.7M
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
72
Open-market trades
since 2006
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where C reports to the SEC

Open-market buys and sales

72 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 7, 2026IONS↓ Sell10b5-1$1.3M
Jul 7, 2026IONS↓ Sell10b5-1$463K
Mar 3, 2026IONS↓ Sell10b5-1$6.7M
Feb 2, 2026IONS↓ Sell$7.1M
Jan 30, 2026IONS↓ Sell$488K
Jan 16, 2026IONS↓ Sell$675K
Sep 5, 2025IONS↓ Sell10b5-1$358K
Sep 3, 2025IONS↓ Sell10b5-1$2.3M
Aug 18, 2025IONS↓ Sell10b5-1$440K
Jan 31, 2025IONS↓ Sell$43K
Jan 16, 2025IONS↓ Sell$222K
Feb 2, 2024IONS↓ Sell$92K
Jan 17, 2024IONS↓ Sell$340K
Dec 21, 2023IONS↓ Sell$1.1M
Dec 14, 2023IONS↓ Sell$1.1M
Sep 28, 2023IONS↓ Sell10b5-1$207K
Feb 6, 2023IONS↓ Sell$74K
Jan 18, 2023IONS↓ Sell$271K
Dec 4, 2020IONS↓ Sell10b5-1$406K
Dec 2, 2020IONS↓ Sell10b5-1$362K
Nov 3, 2020IONS↓ Sell10b5-1$702K
Jun 25, 2020IONS↓ Sell10b5-1$897K
Feb 1, 2019IONS↓ Sell10b5-1$525K
Nov 1, 2018IONS↓ Sell10b5-1$619K
Aug 8, 2018IONS↓ Sell10b5-1$563K
May 11, 2018IONS↓ Sell10b5-1$563K
Jan 16, 2018IONS↓ Sell$140K
Oct 18, 2017IONS↓ Sell10b5-1$796K
Jul 24, 2017IONS↓ Sell10b5-1$593K
Mar 3, 2017IONS↓ Sell10b5-1$275K
Jan 17, 2017IONS↓ Sell$112K
Nov 9, 2016IONS↓ Sell10b5-1$857K
Nov 7, 2016IONS↓ Sell10b5-1$170K
Jan 19, 2016IONS↓ Sell$87K
Dec 16, 2015ISIS↓ Sell10b5-1$454K
Nov 10, 2015ISIS↓ Sell10b5-1$320K
Nov 6, 2015ISIS↓ Sell10b5-1$280K
Mar 24, 2015ISIS↓ Sell10b5-1$1.1M
Jan 16, 2015ISIS↓ Sell$103K
Aug 27, 2014ISIS↓ Sell10b5-1$203K
Jun 23, 2014ISIS↓ Sell$412K
Jan 16, 2014ISIS↓ Sell$38K
Dec 5, 2013ISIS↓ Sell10b5-1$399K
Sep 19, 2013ISIS↓ Sell10b5-1$350K
Sep 9, 2013ISIS↓ Sell10b5-1$302K
May 1, 2013ISIS↓ Sell10b5-1$1.3M
Jan 16, 2013ISIS↓ Sell$4K
Jul 9, 2012ISIS↓ Sell10b5-1$142K
Jul 3, 2012ISIS↓ Sell10b5-1$77K
Dec 21, 2011ISIS↓ Sell10b5-1$11K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IONS insiders

Open-market trades in the last 12 months

About C Frank Bennett's insider trades

C Frank Bennett is EVP, Chief Scientific Officer at Ionis Pharmaceuticals (IONS). Since Feb 9, 2006, C has reported no open-market purchases and 72 sales worth $38.9M on SEC Form 4. In the last 12 months: 6 sales ($16.7M).

54 sales (68% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (65 filings), other transactions (45 filings), grants and awards (39 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IONS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.